TH
Telegraph Hill Partners
Private EquityActiveTelegraph Hill Partners is a California-based private equity firm investing in life sciences, medical device, and healthcare companies.
31
Investments
7
Exits
$1.0B
AUM
22.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Telegraph Hill Partners.
Investment Thesis & Strategy
Telegraph Hill Partners is a private equity firm that invests in life sciences, medical device, and healthcare companies across various stages of development. They seek to partner with management teams to build and grow companies in these sectors.
Investment Activity
Deals per year over the last 7 years
1
20171
20181
20190
20204
20211
20221
2023Portfolio Companies
Selected investments from their portfolio of 31 companies
C
CereVasc
Healthcare · Growth, 2023
T
Theradaptive
Biotech · Growth, 2022
P
ProSomnus
Healthcare · Growth, 2021
V
Vascular Graft Solutions
Healthcare · Growth, 2021
I
InnoLife
Healthcare · Growth, 2021
X
Xenter
Healthcare · Growth, 2021
V
Vascular Therapies
Healthcare · Growth, 2019
V
Vascular Dynamics
Healthcare · Growth, 2018
A
Aptus Endosystems
Healthcare · Growth, 2017
Notable Exits
CompanyTypeYearValue / Acquirer
SientraAcquisition2023$300M
VaxartIPO2020—
Medical SolutionsAcquisition2018—
Vascular SolutionsAcquisition2016$995M
BioDelivery Sciences InternationalIPO2010—
MedAssetsIPO2007—
BioScripIPO2005—
Frequently Asked Questions
Telegraph Hill Partners focuses on Series B, Series C+ stage investments.
Related Investors
Spectrum Equity
San Francisco, United States · 107 deals
Burrill & Company
San Francisco, United States · 87 deals
Foresite Capital
San Francisco, United States · 87 deals
FTV Capital
San Francisco, United States · 78 deals
Francisco Partners
San Francisco, United States · 49 deals
venBio Partners
San Francisco, United States · 48 deals